Corteva Inc. Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.74 (market cap $9.64B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B). The key difference: Corteva Inc. Common Stock and ImmunityBio Inc. Common Stock are close in size by market cap, and Corteva Inc. Common Stock pays a 4.98% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| CTVA | IBRX | |
|---|---|---|
Market Cap | $9.64B | $10.33B |
Volume | 41,241,255 | 11,745,198 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $11.55 |
52-Week Low | $11.92 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $12.15B | $10.79B |
Dividend Yield | 4.98% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →